Cargando…

Resistant Hypertension, Time‐Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus

BACKGROUND: Apparent treatment resistant hypertension (aTRH) is highly prevalent in patients with type 2 diabetes mellitus (T2D) and entails worse cardiovascular prognosis. The impact of aTRH and long‐term achievement of recommended blood pressure (BP) values on renal outcome remains largely unknown...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viazzi, Francesca, Piscitelli, Pamela, Ceriello, Antonio, Fioretto, Paola, Giorda, Carlo, Guida, Pietro, Russo, Giuseppina, De Cosmo, Salvatore, Pontremoli, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634309/ https://www.ncbi.nlm.nih.gov/pubmed/28939716 http://dx.doi.org/10.1161/JAHA.117.006745

Ejemplares similares

Publisher Correction: Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative
por: Piscitelli, Pamela, et al.
Publicado: (2018)

Metabolic syndrome, serum uric acid and renal risk in patients with T2D
por: Viazzi, Francesca, et al.
Publicado: (2017)

Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative
por: Piscitelli, Pamela, et al.
Publicado: (2017)

Antihyperglycemic treatment in patients with type 2 diabetes in Italy: the impact of age and kidney function
por: Gentile, Sandro, et al.
Publicado: (2017)

Diabetic kidney disease in the elderly: prevalence and clinical correlates
por: Russo, Giuseppina T., et al.
Publicado: (2018)

Normoalbuminuric kidney impairment in patients with T1DM: insights from annals initiative
por: Lamacchia, Olga, et al.
Publicado: (2018)

Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes
por: Mirijello, Antonio, et al.
Publicado: (2018)

Five-Year Predictors of Insulin Initiation in People with Type 2 Diabetes under Real-Life Conditions
por: Gentile, Sandro, et al.
Publicado: (2018)

Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitations
por: Leoncini, Giovanna, et al.
Publicado: (2020)

Erratum. Overall Quality of Care Predicts the Variability of Key Risk Factors for Complications in Type 2 Diabetes: An Observational, Longitudinal Retrospective Study. Diabetes Care 2019;42:514–519
por: Ceriello, Antonio, et al.
Publicado: (2020)

Predictors of chronic kidney disease in type 2 diabetes: A longitudinal study from the AMD Annals initiative
por: De Cosmo, Salvatore, et al.
Publicado: (2016)

The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetes
por: Ceriello, Antonio, et al.
Publicado: (2023)

GLP-1 Receptor Agonists and Kidney Protection
por: Greco, Eulalia Valentina, et al.
Publicado: (2019)

Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach
por: Bonino, Barbara, et al.
Publicado: (2019)

Global Cardiovascular Risk Assessment in the Management of Primary Hypertension: The Role of the Kidney
por: Viazzi, Francesca, et al.
Publicado: (2013)

The Burden of NAFLD and Its Characteristics in a Nationwide Population with Type 2 Diabetes
por: Forlani, Gabriele, et al.
Publicado: (2016)

Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient
por: Viazzi, Francesca, et al.
Publicado: (2014)

Non-Haemodynamic Mechanisms Underlying Hypertension-Associated Damage in Target Kidney Components
por: Russo, Elisa, et al.
Publicado: (2023)

Serum Uric Acid Levels Predict New-Onset Type 2 Diabetes in Hospitalized Patients With Primary Hypertension: The MAGIC Study
por: Viazzi, Francesca, et al.
Publicado: (2011)

Antihypertensive Treatment and Renal Protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system
por: Viazzi, Francesca, et al.
Publicado: (2013)

Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age
por: Russo, Elisa, et al.
Publicado: (2020)

SGLT2is and Renal Protection: From Biological Mechanisms to Real-World Clinical Benefits
por: Leoncini, Giovanna, et al.
Publicado: (2021)

Prescription of Sulphonylureas among Patients with Type 2 Diabetes Mellitus in Italy: Results from the Retrospective, Observational Multicentre Cross-Sectional SUSCIPE (Sulphonyl_UreaS_Correct_Internal_Prescription_Evaluation) Study
por: Giorda, Carlo Bruno, et al.
Publicado: (2020)

Treating Hyperuricemia: The Last Word Hasn’t Been Said Yet
por: Russo, Elisa, et al.
Publicado: (2021)

Chronic kidney disease as a predictor of clinical risk in the elderly
por: Viazzi, Francesca, et al.
Publicado: (2016)

Extraosseous effects of vitamin D: a role in the prevention and treatment of COVID-19?
por: Mirijello, Antonio, et al.
Publicado: (2022)

Age- and Gender-Related Differences in LDL-Cholesterol Management in Outpatients with Type 2 Diabetes Mellitus
por: Russo, Giuseppina, et al.
Publicado: (2015)

Factors Associated with Beta-Cell Dysfunction in Type 2 Diabetes: The BETADECLINE Study
por: Russo, Giuseppina T., et al.
Publicado: (2014)

Target Values of Cardiovascular Risk Factors Are Not Associated with All-Cause Mortality in Patients with Type 2 Diabetes Mellitus
por: Pacilli, Antonio, et al.
Publicado: (2015)

Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?
por: Leoncini, Giovanna, et al.
Publicado: (2022)

Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus
por: Fioretto, Paola, et al.
Publicado: (2015)

Determinants of good metabolic control without weight gain in type 2 diabetes management: a machine learning analysis
por: Giorda, Carlo Bruno, et al.
Publicado: (2020)

Pulmonary Artery Stump Thrombosis: To Treat or Not to Treat? The Question Is Still Open. Description of a Case and Review of the Literature
por: Mirijello, Antonio, et al.
Publicado: (2021)

The diagnostic value of supine blood pressure in hypertension
por: Krzesiński, Paweł, et al.
Publicado: (2016)

Role of Uric Acid in Vascular Remodeling: Cytoskeleton Changes and Migration in VSMCs
por: Russo, Elisa, et al.
Publicado: (2023)

Chronic Thromboembolic Pulmonary Hypertension: An Update
por: Ruaro, Barbara, et al.
Publicado: (2022)

Uric Acid Promotes Apoptosis in Human Proximal Tubule Cells by Oxidative Stress and the Activation of NADPH Oxidase NOX 4
por: Verzola, Daniela, et al.
Publicado: (2014)

Hypertension in the elderly: which are the blood pressure threshold values?
por: Volpe, Massimo, et al.
Publicado: (2019)

Preclinical update on regulation of intracranial pressure in relation to idiopathic intracranial hypertension
por: Eftekhari, Sajedeh, et al.
Publicado: (2019)

Updates on cardiovascular outcome trials in diabetes
por: Schnell, Oliver, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uatlb846c57hiai62mb0m4o633